Get all your news in one place.
100's of premium titles.
One app.
Start reading
The Guardian - UK
The Guardian - UK
Politics
Ian Sample Science editor

What impact will Alzheimer’s drug donanemab have?

Evidence of Alzheimer’s disease on PET scans
Evidence of Alzheimer’s disease on PET scans. Photograph: Brian Snyder/Reuters

A major clinical trial of an Alzheimer’s drug has confirmed that the therapy can slow the rate at which patients deteriorate, raising hopes that medicine may one day halt the most common form of dementia. What impact could the new drug have?

What is the new drug?

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.